Center for Pharmaceutical Policy and Prescribing

Center News

New Staff

In February, we welcomed a new staff member to CP3! Dr. Abigail Foulds joined CP3 via the Division of General Internal Medicine as the Project Manager for Dr. Jing Luo’s recently funded AnHuT1D trial. Dr. Foulds’ experiences living and traveling in the Global South, plus her interest in international health, drew her to Dr. Luo’s project. Before joining CP3, Dr. Foulds worked with Dr. Todd Bear to grow the Evaluation Institute in the Department of Behavioral and Community Health Sciences in the School of Public Health where she oversaw public health data collection. Dr. Foulds received her PhD (2014) and MA (2007) in Geography from the University of Kentucky. Welcome, Abby!


Faculty Awards

Dr. Katie Suda earned two new honors.  She was added to the editorial board of the American Journal of Health-System Pharmacy for a two-year term, and she received the Pittsburgh Federal Executive Board for the VA’s Excellence in Government Award for Contribution to Science (medical). Congratulations!



We’ve made pharmacoequity one of our core missions. Learn more on May 20 at the first-ever Pharmacoequity Conference, featuring keynote speaker Dr. Jasmine Marcelin and research and policy panels. More details to come!


Research Highlight

The COVID-19 pandemic has upended just about every aspect of heath care, including the global drug supply chain. Even though the drug supply chain is known to be susceptible to disruptions, the impact of drug shortages during a global public health emergency is unknown. Dr. Katie Suda received a grant from AHRQ to study that impact and the effectiveness of strategies to alleviate shortages caused by supply chain disruptions. This project will give policymakers real world evidence to plan for future pandemics and global health emergencies.

Grants Funded

Dr. Jing Luo is the PI for a project for which the University of Pittsburgh has been awarded a $3.5M grant from The Leona M. and Harry B. Helmsley Charitable Trust. Dr. Luo will partner with Co-I Dr. Sylvia Kehlenbrink, a clinical endocrinologist and director of the Program on Global Endocrinology at Brigham and Women’s Hospital, for the study, “Analogue vs Human Insulin for Youth with Type 1 Diabetes in Low-Resource Settings: A Randomized Controlled Trial (AnHuT1D trial).” The team will also partner with Life for a Child, the London School of Hygiene & Tropical Medicine (LSHTM), and the Clinton Health Access Initiative (CHAI) to conduct an international randomized controlled trial comparing insulin glargine, a long-acting analogue insulin, against human insulin, among children and young adults living with Type 1 Diabetes (T1D) in lower resource settings.

Dr. Walid Gellad and Dr. Eric Roberts, faculty in the Department of Health Policy and Management at Pitt Public Health, received a four year VA HSR&D Merit grant for their project, “Leveraging a Natural Experiment to Identify the Effects of VA Community Care Programs on Health Care Quality, Equity, and Veteran Experiences.”

Dr. Kangho Suh received a subaward to develop cost-effectiveness models for the Institute of Clinical and Economic Review (ICER) in collaboration with Dr. Josh Carlson from University of Washington as part of ICER's drug assessment program. Drs. Suh and Carlson will develop cost-effectiveness models for two topics (to be determined) for ICER in 2022.

Selected Recently Published Papers

Trends in Opioid Prescribing by General Dentists and Dental Specialists in the U.S., 2012–2019
Connie H. Yan PharmD, PhD, Todd A. Lee PharmD, PhD, Lisa K. Sharp PhD, Colin C. Hubbard PhD, Charlesnika T. Evans PhD, MPH, Gregory S. Calip PharmD, MPH, PhD, Susan A. Rowan DDS, MS, Jessina C. McGregor PhD, Walid F. Gellad MD, MPH, Katie J. Suda PharmD, MS
American Journal of Preventive Medicine, February 26, 2022

Incidence and Predictors of Primary Nonadherence to Sodium Glucose Co-transporter 2 Inhibitors and Glucagon-Like Peptide 1 Agonists in a Large Integrated Healthcare System
Jing Luo MD, MPH, Robert Feldman BS, Scott Rothenberger PhD, Mary Korytkowski MD, Michael A. Fischer MD, MS, & Walid F. Gellad MD, MPH
Journal of General Internal Medicine, January 19, 2022

Myocarditis after vaccination against covid-19
Walid Gellad
The BMJ, December 16, 2021

Latent Class Analysis of Prescribing Behavior of Primary Care Physicians in the Veterans Health Administration
Alexis K. Barrett PharmD, John P. Cashy PhD, Carolyn T. Thorpe PhD, MPH, Jennifer A. Hale BA, Kangho Suh PharmD PhD, Bruce L. Lambert PhD, William Galanter MD PhD, Jeffrey A. Linder MD MPH, Gordon D. Schiff MD, & Walid F. Gellad MD MPH
Journal of General Internal Medicine, January 6, 2022

Appropriateness of Antibiotic Prophylaxis Before Dental Procedures, 2016-2018
Colin C Hubbard, Charlesnika T Evans, Gregory S Calip, Jifang Zhou, Susan A Rowan, Katie J Suda
American Journal of Preventive Medicine, January 7, 2022

Association of Race and Ethnicity and Anticoagulation in Patients with Atrial Fibrillation Dually Enrolled in VA and Medicare: Effects of Medicare Part D on Prescribing Disparities
Utibe R. Essien, Nadejda Kim, Jared W. Magnani, Chester B. Good, Terrence M. A. Litam, Leslie R. M. Hausmann, Maria K. Mor, Walid F. Gellad, and Michael J. Fine
Circulation: Cardiovascular Quality and Outcomes, November 15, 2021


In the Media

Dr. Utibe Essien was named one of MedPage Today's "15 Black Doctors on Social Media You Need to Follow."   Follow Dr. Essien on Twitter here.

When Merck's Covid pill was approved for high-risk adults, Dr. Walid Gellad told the New York Times, "I don’t think Merck’s version is going to be the game changer." Gellad spoke with the NYT again about about how regulators might weigh their decisions to approve a Covid vaccine for the youngest kids.

"Why is the cost of insulin so high?" is a perennial question. Dr. Jing Luo joined NPR's Here and Now to explain why insulin has a high price and what might happen to the price as a result of the Build Back Better bill. Dr. Luo also spoke with The Buffalo News and Fortune about insulin prices.


Once again, CP3 will be well-represented at the SGIM Annual Meeting in April. Attending the conference? Don’t miss these presentations!


Many of our faculty and staff will be presenting their work at the AcademyHealth Annual Research Meeting in June. Here’s a preview of what to expect. We'll continue to update our events page with the full list.


University of Pittsburgh